查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1316752

CRISPR 和 Cas 基因市场：按组件（产品、服务）、用途（农业、生物医学）、最终用户 - 2023-2030 年全球预测

CRISPR & Cas Genes Market by Component (Product, Service), Application (Agricultural, Biomedical), End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2023 年 CRISPR 和 Cas 基因的全球市场将达到 3813.43 百万美元，年复合成长率为 32.38%，预计到 2030 年将出现惊人的增长，达到 2721127 万美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球CRISPR&Cas基因市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.CRISPR&Cas基因的全球市场规模及预测为何？

2. 在预测期内，COVID-19 对全球 CRISPR 和 Cas Gene 市场的阻碍因素和影响有哪些？

3.在预测期内，全球CRISPR和Cas基因市场需要投资哪些产品/细分市场/应用/领域？

4.全球CRISPR&Cas基因市场的竞争策略为何？

5.全球CRISPR&Cas基因市场的技术趋势与法律规范是什么？

6.全球CRISPR&Cas基因市场主要厂商的市占率是多少？

7.型态和策略措施被认为适合CRISPR&Cas基因进入全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 开发基于 CRISPR 的样本组织筛选诊断方法
      • 遗传疾病罹患率率高
      • 增加在药物研发、医学研究和非基因改造出血的应用
    • 抑制因素
      • CRISPR技术的脱靶效应
    • 机会
      • 抗CRISPR蛋白的进化
      • CRISPR-Cas基因新应用的研发
    • 任务
      • 专利形势与纠纷
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章CRISPR 和 Cas 基因市场：按组成部分

  • 产品
    • 抗体
    • 设计工具
    • 试剂盒和酶
      • 无 DNA 钙
      • 基于向量的Cas
    • 图书馆
  • 服务
    • 细胞株工程
    • DNA合成
    • gRNA设计
    • 微生物基因编辑

第7章CRISPR 和 Cas 基因市场：按用途

  • 农业
  • 生物医学医学
    • 疾病模型研究
    • 表观遗传学
    • 功能基因体学
    • 基因组工程

第8章CRISPR 和 Cas 基因市场：按最终用户分类

  • 学术和政府研究机构
  • 生物技术和製药公司
  • 合约研究组织

第9章美洲CRISPR和Cas基因市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太CRISPR和Cas基因市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲的CRISPR和Cas基因市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-5642D503D850

The Global CRISPR & Cas Genes Market is forecasted to grow significantly, with a projected USD 3,813.43 million in 2023 at a CAGR of 32.38% and expected to reach a staggering USD 27,211.27 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global CRISPR & Cas Genes Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global CRISPR & Cas Genes Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Component, market is studied across Product and Service. The Product is further studied across Antibodies, Design Tool, Kits & Enzymes, and Libraries. The Kits & Enzymes is further studied across DNA-Free Cas and Vector-Based Cas. The Service is further studied across Cell Line Engineering, DNA Synthesis, gRNA Design, and Microbial Gene Editing. The Product is projected to witness significant market share during forecast period.

Based on Application, market is studied across Agricultural and Biomedical. The Biomedical is further studied across Disease Model Studies, Epigenetics, Functional Genomics, and Genome Engineering. The Biomedical is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Academics & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations. The Biotechnology & Pharmaceutical Companies is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global CRISPR & Cas Genes Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global CRISPR & Cas Genes Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global CRISPR & Cas Genes Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global CRISPR & Cas Genes Market?

4. What is the competitive strategic window for opportunities in the Global CRISPR & Cas Genes Market?

5. What are the technology trends and regulatory frameworks in the Global CRISPR & Cas Genes Market?

6. What is the market share of the leading vendors in the Global CRISPR & Cas Genes Market?

7. What modes and strategic moves are considered suitable for entering the Global CRISPR & Cas Genes Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. CRISPR & Cas Genes Market, by Component, 2022 vs 2030
  • 4.3. CRISPR & Cas Genes Market, by Application, 2022 vs 2030
  • 4.4. CRISPR & Cas Genes Market, by End-user, 2022 vs 2030
  • 4.5. CRISPR & Cas Genes Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Development of CRISPR-based diagnostic assays for sample tissue screening
      • 5.1.1.2. High prevalence of genetic disorders
      • 5.1.1.3. Rising application in drug discovery, biomedical research, and non-transgenic bleeding
    • 5.1.2. Restraints
      • 5.1.2.1. Off-target effects of CRISPR technology
    • 5.1.3. Opportunities
      • 5.1.3.1. Evolution of anti-CRISPR protein
      • 5.1.3.2. Research and development for novel application of CRISPR-Cas genes
    • 5.1.4. Challenges
      • 5.1.4.1. Patent landscape and dispute
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. CRISPR & Cas Genes Market, by Component

  • 6.1. Introduction
  • 6.2. Product
    • 6.2.1. Antibodies
    • 6.2.2. Design Tool
    • 6.2.3. Kits & Enzymes
      • 6.2.3.1. DNA-Free Cas
      • 6.2.3.2. Vector-Based Cas
    • 6.2.4. Libraries
  • 6.3. Service
    • 6.3.1. Cell Line Engineering
    • 6.3.2. DNA Synthesis
    • 6.3.3. gRNA Design
    • 6.3.4. Microbial Gene Editing

7. CRISPR & Cas Genes Market, by Application

  • 7.1. Introduction
  • 7.2. Agricultural
  • 7.3. Biomedical
    • 7.3.1. Disease Model Studies
    • 7.3.2. Epigenetics
    • 7.3.3. Functional Genomics
    • 7.3.4. Genome Engineering

8. CRISPR & Cas Genes Market, by End-user

  • 8.1. Introduction
  • 8.2. Academics & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas CRISPR & Cas Genes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific CRISPR & Cas Genes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa CRISPR & Cas Genes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CRISPR & CAS GENES MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR & CAS GENES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
  • FIGURE 5. CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. CRISPR & CAS GENES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. CRISPR & CAS GENES MARKET DYNAMICS
  • FIGURE 9. CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. CRISPR & CAS GENES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CRISPR & CAS GENES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CRISPR & CAS GENES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 5. CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CRISPR & CAS GENES MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CRISPR & CAS GENES MARKET SIZE, BY DESIGN TOOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 10. CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CRISPR & CAS GENES MARKET SIZE, BY DNA-FREE CAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CRISPR & CAS GENES MARKET SIZE, BY VECTOR-BASED CAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CRISPR & CAS GENES MARKET SIZE, BY LIBRARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 15. CRISPR & CAS GENES MARKET SIZE, BY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CRISPR & CAS GENES MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CRISPR & CAS GENES MARKET SIZE, BY DNA SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. CRISPR & CAS GENES MARKET SIZE, BY GRNA DESIGN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. CRISPR & CAS GENES MARKET SIZE, BY MICROBIAL GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CRISPR & CAS GENES MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 23. CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. CRISPR & CAS GENES MARKET SIZE, BY DISEASE MODEL STUDIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. CRISPR & CAS GENES MARKET SIZE, BY EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. CRISPR & CAS GENES MARKET SIZE, BY FUNCTIONAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. CRISPR & CAS GENES MARKET SIZE, BY GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CRISPR & CAS GENES MARKET SIZE, BY ACADEMICS & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. CRISPR & CAS GENES MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. CRISPR & CAS GENES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY KITS & ENZYMES, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY BIOMEDICAL, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM CRISPR & CAS GENES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 323. CRISPR & CAS GENES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 324. CRISPR & CAS GENES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 325. CRISPR & CAS GENES MARKET LICENSE & PRICING